Chronic Pain News and Research

RSS

FDA grants priority review status for Endo’s oxymorphone oral formulation

Endo Pharmaceuticals announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be crush resistant, has been granted priority review status.

23 Sep 2010

APF launches new educational initiative for people with pain, health care professionals

The American Pain Foundation today announced the launch of PainSAFE (Pain Safety & Access For Everyone), a new educational initiative designed for people with pain and health care professionals. The mission of PainSAFE is to provide education surrounding the appropriate and safe use of pain management therapies for people affected by pain and health care professionals, thereby, helping to reduce risk and improve access to quality pain care.

22 Sep 2010

Communication breakdown exists between people with chronic pain, health care providers: Survey

Conversations with health care providers can be challenging at times for all patients, but a new survey commissioned by HealthyWomen and conducted by Synovate Healthcare in July of 2010 reveals a concerning communications breakdown between people with chronic pain and their health care providers. More than one-third of chronic pain sufferers (36%) have simply learned to live with their often debilitating pain and may be reluctant to speak with a health care provider about their condition, according to a survey of women and men with chronic pain released today.

22 Sep 2010

Researchers discover new drug to control acute and chronic pain

American and Italian researchers have found that a novel drug allows anandamide a marijuana like chemical in the body to effectively control pain at the site of an injury.

21 Sep 2010

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Athena™ programmer, a deep brain stimulation (DBS) therapy management system. This next-generation platform offers clinicians a powerful yet easy-to-use interface that enables them to set or adjust therapeutic parameters to optimize patient results.

20 Sep 2010

$ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study$

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

Medtronic, Inc. announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise for occipital nerve stimulation for treating medically refractory chronic migraines and support the need for further controlled study of the treatment. The study, called Occipital Nerve Stimulation for the Treatment of Intractable Migraine, included severely debilitated patients who had regularly experienced 15 or more headache days per month that were not responsive to currently available medical therapies.

18 Sep 2010

ACTION Ontario applauds Narcotics Safety and Awareness bill

ACTION Ontario, a non-profit group advocating on behalf of chronic pain sufferers, applauds the provincial government's Narcotics Safety and Awareness bill and encourages the government to take the next step and also address the underlying issue of pain with a comprehensive strategy.

17 Sep 2010

Spike mat reduces muscle tension pain: Study

Spike mats do not alleviate chronic pain. Nor do they lead to a better night's sleep. But pain sufferers who have tested a spike mat did experience a measurable reduction in the worst peaks of pain. This is shown in a research study performed at Karlstad University in Sweden.

17 Sep 2010

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

The American Pain Foundation reports that despite the fact that the majority of the U.S. population looks healthy, statistics tell a different story: Approximately 1 in 3 Americans suffer from chronic pain. This chronic pain could be related to an illness like cancer or rheumatoid arthritis, or a condition such as arthritis, migraine headaches, fibromyalgia or back pain from a car accident.

15 Sep 2010

FDA grants Arcion's ARC-4558 Fast Track designation for pain involved in Painful Diabetic Neuropathy

Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ARC-4558 for the treatment of pain associated with Painful Diabetic Neuropathy (PDN).

15 Sep 2010

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.

14 Sep 2010

RS Medical receives Federal Supply Schedule contract

International Rehabilitative Sciences, Inc. d/b/a RS Medical, announced today its first award of a Federal Supply Schedule contract. The contract is in effect through June 14, 2015.

14 Sep 2010

Diamyd Medical reports potential results on NP2 Phase I clinical trial for chronic pain

Diamyd Medical AB, to date no drug related Serious Adverse Events have been reported by any patient included in Diamyd's Phase I clinical trial investigating NP2 as a potential therapy for chronic pain. Based upon the Phase I findings to date, the company is planning a multi-center, randomized, double-blind, placebo controlled Phase II clinical trial with NP2 in the United States.

13 Sep 2010

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Purdue Pharma L.P. will present data from the clinical program for Butrans™ (buprenorphine) Transdermal System CIII in a series of posters at PAINWeek®2010, September 8-10 in Las Vegas.

10 Sep 2010

Researchers to develop two-way fiber optic communication between prosthetic limbs and peripheral nerves

Lightning fast connections between robotic limbs and the human brain may be within reach for injured soldiers and other amputees with the establishment of a multimillion-dollar research center led by SMU engineers.

10 Sep 2010

C.A.R.E.S. Alliance launches online tools for addressing misuse and abuse of pain medications

The C.A.R.E.S. Alliance, a new patient safety organization, today launched a range of online tools designed to help solve the growing problem of misuse and abuse of opioids by identifying the risks associated with these powerful pain medications. The free resources offered through the C.A.R.E.S. (Collaborating & Acting Responsibly to Ensure Safety) Alliance promote safety in prescribing, dispensing, using, storing and disposing of these commonly abused pain medications.

9 Sep 2010

Researchers discover tolerance mechanism in chronic morphine treatment

Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling.

8 Sep 2010

Study finds acupuncture can control side effects of cancer treatment

Recent studies have shown that acupuncture can help control a number of symptoms and side effects such as pain, fatigue, dry mouth, nausea, and vomiting associated with a variety of cancers and their treatments.

3 Sep 2010

Governments called upon to recognize that access to pain management is a fundamental human right

Health care providers and researchers in the field of pain management are calling for governments worldwide to recognize the rights of people to the access of reasonable care for acute and chronic pain.

3 Sep 2010

ASIPP announces educational campaign to improve chronic pain patients’ quality of life

In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.

3 Sep 2010

Chronic Pain News and Research

FDA grants priority review status for Endo’s oxymorphone oral formulation

APF launches new educational initiative for people with pain, health care professionals

Communication breakdown exists between people with chronic pain, health care providers: Survey

Researchers discover new drug to control acute and chronic pain

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

ONS trial results show promise for treating medically refractory chronic migraines: ONSTIM study

ACTION Ontario applauds Narcotics Safety and Awareness bill

Spike mat reduces muscle tension pain: Study

FDA-cleared LaserTouchOne device for chronic and acute pain treatment available without prescription

FDA grants Arcion's ARC-4558 Fast Track designation for pain involved in Painful Diabetic Neuropathy

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

RS Medical receives Federal Supply Schedule contract

Diamyd Medical reports potential results on NP2 Phase I clinical trial for chronic pain

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Researchers to develop two-way fiber optic communication between prosthetic limbs and peripheral nerves

C.A.R.E.S. Alliance launches online tools for addressing misuse and abuse of pain medications

Researchers discover tolerance mechanism in chronic morphine treatment

Study finds acupuncture can control side effects of cancer treatment

Governments called upon to recognize that access to pain management is a fundamental human right

ASIPP announces educational campaign to improve chronic pain patients’ quality of life

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News